Semaglutide & Tirzepatide for PCOS: Treating the Root Cause
Researchers isolated this specific sequence because early work showed it retained growth hormones fat-burning properties without triggering the broader hormonal cascade that affects growth, blood sugar, and tissue development
Semaglutide, marketed as Ozempic, Rybelsus, and Wegovy, accounts for over 30% of market share on its own
Weight loss failure on tirzepatide usually traces back to insufficient dose (need to escalate further), caloric intake still exceeding expenditure despite reduced appetite, metabolic adaptation, or underlying medical conditions like hypothyroidism or PCOS that require separate treatment
*The Herbalife GLP-1 Nutrition Companion is not a drug and has not been clinically evaluated in GLP-1 patients